223 related articles for article (PubMed ID: 27373552)
21. Role of fibrinolytic and clotting parameters in the diagnosis of liver veno-occlusive disease after hematopoietic stem cell transplantation in a pediatric population.
Sartori MT; Spiezia L; Cesaro S; Messina C; Paris M; Pillon M; Saggiorato G; Pagnan A; Girolami A; Zanesco L; Cella G
Thromb Haemost; 2005 Apr; 93(4):682-9. PubMed ID: 15841312
[TBL] [Abstract][Full Text] [Related]
22. The incidence of veno-occlusive disease following allogeneic hematopoietic stem cell transplantation has diminished and the outcome improved over the last decade.
Carreras E; Díaz-Beyá M; Rosiñol L; Martínez C; Fernández-Avilés F; Rovira M
Biol Blood Marrow Transplant; 2011 Nov; 17(11):1713-20. PubMed ID: 21708110
[TBL] [Abstract][Full Text] [Related]
23. Veno-occlusive disease in children and adolescents after hematopoietic stem cell transplantation: Did the Modified Seattle Criteria fit the characteristics of pediatric population?
Szmit Z; Gorczyńska E; Mielcarek-Siedziuk M; Ussowicz M; Owoc-Lempach J; Kałwak K
Adv Clin Exp Med; 2020 Mar; 29(3):339-344. PubMed ID: 32207590
[TBL] [Abstract][Full Text] [Related]
24. Defibrotide for the treatment of hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation.
Corbacioglu S; Kernan N; Lehmann L; Brochstein J; Revta C; Grupp S; Martin P; Richardson PG
Expert Rev Hematol; 2012 Jun; 5(3):291-302. PubMed ID: 22780209
[TBL] [Abstract][Full Text] [Related]
25. Hepatic veno-occlusive disease.
Ribaud P; Gluckman E
Pediatr Transplant; 1999; 3 Suppl 1():41-4. PubMed ID: 10587970
[TBL] [Abstract][Full Text] [Related]
26. Burden of illness associated with sinusoidal obstruction syndrome/veno-occlusive disease in patients with hematopoietic stem cell transplantation.
Cao Z; Villa KF; Lipkin CB; Robinson SB; Nejadnik B; Dvorak CC
J Med Econ; 2017 Aug; 20(8):871-883. PubMed ID: 28562132
[TBL] [Abstract][Full Text] [Related]
27. Experience from a single paediatric transplant centre with identification of some protective and risk factors concerning the development of hepatic veno-occlusive disease in children after allogeneic hematopoietic stem cell transplant.
Maximova N; Ferrara G; Minute M; Pizzol A; Kiren V; Montico M; Gregori M; Tamaro P
Int J Hematol; 2014 Jun; 99(6):766-72. PubMed ID: 24715523
[TBL] [Abstract][Full Text] [Related]
28. Coexisting or underlying risk factors of hepatic veno-occlusive disease in pediatric hematopoietic stem cell transplant recipients receiving prophylaxis.
Gökce M; Kuskonmaz B; Cetin M; Uckan Cetinkaya D; Tuncer M
Exp Clin Transplant; 2013 Oct; 11(5):440-6. PubMed ID: 24128137
[TBL] [Abstract][Full Text] [Related]
29. Danaparoid as the prophylaxis for hepatic veno-occlusive disease after allogeneic hematopoietic stem cell transplantation in childhood hematological malignancy.
Sakaguchi H; Watanabe N; Muramatsu H; Doisaki S; Yoshida N; Matsumoto K; Kato K
Pediatr Blood Cancer; 2010 Dec; 55(6):1118-25. PubMed ID: 20589662
[TBL] [Abstract][Full Text] [Related]
30. Contribution of fibrinolytic tests to the differential diagnosis of veno-occlusive disease complicating pediatric hematopoietic stem cell transplantation.
Sartori MT; Cesaro S; Peruzzo M; Messina C; Saggiorato G; Calore E; Pillon M; Varotto S; Spiezia L; Cella G
Pediatr Blood Cancer; 2012 May; 58(5):791-7. PubMed ID: 21674760
[TBL] [Abstract][Full Text] [Related]
31. Hepatic veno-occlusive disease (sinusoidal obstruction syndrome) after hematopoietic stem cell transplantation.
Kumar S; DeLeve LD; Kamath PS; Tefferi A
Mayo Clin Proc; 2003 May; 78(5):589-98. PubMed ID: 12744547
[TBL] [Abstract][Full Text] [Related]
32. Veno-occlusive disease in hematopoietic stem cell transplantation recipients.
Sosa EC
Clin J Oncol Nurs; 2012 Oct; 16(5):507-13. PubMed ID: 23022934
[TBL] [Abstract][Full Text] [Related]
33. Veno-occlusive disease/sinusoidal obstruction syndrome after haematopoietic stem cell transplantation: Middle East/North Africa regional consensus on prevention, diagnosis and management.
Al Jefri AH; Abujazar H; Al-Ahmari A; Al Rawas A; Al Zahrani Z; Alhejazi A; Bekadja MA; Ibrahim A; Lahoucine M; Ousia S; Bazarbachi A
Bone Marrow Transplant; 2017 Apr; 52(4):588-591. PubMed ID: 27892944
[TBL] [Abstract][Full Text] [Related]
34. Idiopathic refractory ascites after allogeneic stem cell transplantation: a previously unrecognized entity.
Varma A; Abraham SC; Mehta RS; Saini NY; Honhar M; Rashid M; Chen J; Srour SA; Bashir Q; Rondon G; Oran B; Hosing CM; Nieto Y; Kebriaei P; Alousi AM; Ahmed S; Marin D; Khouri IF; Ciurea SO; Qazilbash MH; Rezvani K; Anderlini P; Andersson BS; Shpall EJ; Champlin RE; Popat UR
Blood Adv; 2020 Apr; 4(7):1296-1306. PubMed ID: 32236526
[TBL] [Abstract][Full Text] [Related]
35. Marked reduction in the incidence of hepatic veno-occlusive disease after allogeneic hematopoietic stem cell transplantation with CD34(+) positive selection.
Moscardó F; Sanz GF; de La Rubia J; Jiménez C; Saavedra S; Regadera A; Andreu R; García I; Plumé G; Martínez J; Martín G; Jarque I; Sanz MA
Bone Marrow Transplant; 2001 May; 27(9):983-8. PubMed ID: 11436110
[TBL] [Abstract][Full Text] [Related]
36. Hepatic veno-occlusive disease--liver toxicity syndrome after bone marrow transplantation.
Shulman HM; Hinterberger W
Bone Marrow Transplant; 1992 Sep; 10(3):197-214. PubMed ID: 1422475
[TBL] [Abstract][Full Text] [Related]
37. The role of peritoneal drainage in veno-occlusive disease in pediatric patients post hematopoietic stem cell transplant.
Mashegu H; Smith L; Li Y; Seif A; Grupp S; Bunin N
Bone Marrow Transplant; 2018 Jul; 53(7):938-941. PubMed ID: 29410550
[No Abstract] [Full Text] [Related]
38. Hepatic veno-occlusive disease after hematopoietic stem cell transplantation: update on defibrotide and other current investigational therapies.
Ho VT; Revta C; Richardson PG
Bone Marrow Transplant; 2008 Feb; 41(3):229-37. PubMed ID: 17994121
[TBL] [Abstract][Full Text] [Related]
39. The budget impact and cost-effectiveness of defibrotide for treatment of veno-occlusive disease with multi-organ dysfunction in patients post-hematopoietic stem cell transplant.
Veenstra DL; Guzauskas GF; Villa KF; Boudreau DM
J Med Econ; 2017 May; 20(5):453-463. PubMed ID: 28008770
[TBL] [Abstract][Full Text] [Related]
40. [Sinusoidal obstruction disease (SOS), previous hepatic venoocclusive disease (VOD)--still serious complication after hematopoietic stem cell transplantation].
Gozdzik J; Krasowska-Kwiecień A; Wedrychowicz A
Przegl Lek; 2008; 65(4):203-8. PubMed ID: 18724548
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]